Search

everythinglearnresearchcommunity

for

Search:↓

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

People with alopecia areata have higher insulin resistance.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Greying hairs may be protected from alopecia areata.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.